Validation of an immunomodulatory gene signature algorithm to predict response to neoadjuvant immunochemotherapy in patients with primary triple-negative breast cancer.

Toshiaki Iwase,Lajos Pusztai,Kim R.M. Blenman,Xiaotong Li,Robert S. Seitz,Tyler J. Nielsen,Brock L. Schweitzer,David R. Hout,Dan B Bailey,Xiang Zhang,Yichao Shen,Naoto T. Ueno

Validation of an immunomodulatory gene signature algorithm to predict response to neoadjuvant immunochemotherapy in patients with primary triple-negative breast cancer.

2020

Toshiaki Iwase
Lajos Pusztai
Kim R.M. Blenman
Xiaotong Li
Robert S. Seitz
Tyler J. Nielsen
Brock L. Schweitzer
David R. Hout
Dan B Bailey
Xiang Zhang
Yichao Shen
Naoto T. Ueno

3117Background: A 101-gene algorithm established as a molecular subtyping method for triple-negative breast cancer (TNBC) includes assignment of an immunomodulatory (IM) subtype based on genes acti...

Keywords:

Gene
Gene signature
Algorithm
Triple-negative breast cancer
Breast cancer
in patient
Medicine
Subtyping

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations